Heart-sparing effect of postmastectomy radiotherapy for breast cancer patients: A dosimetric study of cardiac substructures

Individual benefit in heart sparing during DIBH-supported left breast radiotherapy

“…Many volumes of interest and dose constraints have been used in practice for the study of heart dose, such as the MHD, heart V25Gy, LAD mean dose and LAD maximum dose [2] , [3] , [8] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] . The recently introduced LV dosimetry is more and more used [9] , [10] , [14] .…”

“…Many volumes of interest and dose constraints have been used in practice for the study of heart dose, such as the MHD, heart V25Gy, LAD mean dose and LAD maximum dose [2] , [3] , [8] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] . The recently introduced LV dosimetry is more and more used [9] , [10] , [14] . With the aim of optimizing dose reporting a new organ at risk (OAR) volume the LAD region (LADR) has been described; that approach intended to improve delineation consistency if performed without contrast-enhanced CT by including the LAD and its branches in a more generous subvolume than just the LAD [17] .…”